Bone Morphogenetic Protein (BMP) Market Summary
According to the new market research report “Global Bone Morphogenetic Protein (BMP) Market Report 2024-2030”, published by QYResearch, the global Bone Morphogenetic Protein (BMP) market size is projected to reach USD 1.19 billion by 2030, at a CAGR of 8.7% during the forecast period.
Figure. Global Bone Morphogenetic Protein (BMP) Market Size (US$ Million), 2019-2030
Figure. Global Bone Morphogenetic Protein (BMP) Top3 Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)
According to QYResearch Top Players Research Center, the global key manufacturers of Bone Morphogenetic Protein (BMP) include Medtronic, Jiuyuan Gene Engineering, etc. In 2023, the global top three players had a share approximately 99.0% in terms of revenue.
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance. Human recombinant BMP7 has surgical uses and was originally marketed under the brand name OP1 (Olympus Biotech, who bought it from Stryker). It can be used to aid in the fusion of vertebral bodies to prevent neurologic trauma. rhBMP-7 has withdrawn off the market. rhBMP-4 and rhBMP-6 do not have commercial product launched. Therefore, in this report, we only study the rhBMP-2.
The increasing demand for Bone Morphogenetic Protein (BMP) 2 is primarily driven by its remarkable efficacy in promoting bone growth and facilitating spinal fusion procedures. As a potent osteoinductive agent, BMP-2 plays a crucial role in stimulating the differentiation of mesenchymal stem cells into osteoblasts, thereby accelerating bone formation. This capability addresses the rising prevalence of orthopedic conditions and musculoskeletal disorders, particularly in aging populations. Consequently, BMP-2 stands out as a pivotal driver in the orthobiologics market, offering effective solutions for bone regeneration and enhancing patient outcomes in orthopedic surgeries.
Despite its significant therapeutic potential, the adoption of Bone Morphogenetic Protein (BMP) 2 faces challenges stemming from regulatory scrutiny and safety concerns. Ectopic bone formation and inflammatory reactions associated with BMP-2 usage have raised apprehensions among regulatory authorities and healthcare providers. Stricter regulatory requirements demand comprehensive safety assessments and rigorous monitoring of adverse effects, thereby posing challenges to market penetration and adoption rates. Addressing these concerns through robust clinical data and adherence to stringent regulatory standards is essential to mitigate risks and foster the sustainable growth of the BMP-2 market.
About The Authors
| Zhang Xiao - Lead Author |
| Email: zhangxiao@qyresearch.com |
| Zhang Xiao is a market senior analyst specializing in medical device, pharma, Lab consumable. Zhang Xiao has 8 years’ experience in medical device and pharma market analysis, and focuses on medical device and consumables (imaging equipment, medical consumables, wearable medical equipment, medical robots, home care equipment, dental equipment, implant equipment, operating room equipment, in vitro diagnostics, etc.) and drugs (API, finished drugs, patented drugs, blood products , vaccines, etc.) . She is engaged in the development of technology and market reports and is also involved in custom projects. |
About QYResearch
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.
QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.